Water extract of Spatholobus suberectus inhibits osteoclast differentiation and bone resorption

BMC Complementary and Alternative Medicine

Jin Yeul Ma¹  Taesoo Kim¹  Hyosun An¹  Ki-Shuk Shim¹  Hyunil Ha¹ 

[1]KM-Based Herbal Drug Research Group, Korea Institute of Oriental Medicine, Daejeon, 305-811, Republic of Korea

关键词: Bone resorption;    Osteoclasts;    RANKL;    Spatholobus suberectus;    Osteoporosis;   

Others  :  1229942
DOI  :  10.1186/1472-6882-13-112

 received in 2013-01-29, accepted in 2013-05-14,  发布年份 2013

【 摘 要 】

Background

Osteoclasts are primarily responsible for bone resorption. In many pathological bone diseases including osteoporosis and rheumatoid arthritis, osteoclasts are excessively activated. Thus, controlling of osteoclasts would be an effective therapeutic strategy for the treatment of excessive bone loss. The stem of Spatholobus suberectus has been widely used in traditional medicine to treat blood stasis syndrome and arthritis in Asia. In the present study, we investigated the effects and action mechanism of water extract of the stem of Spatholobus suberectus (WESS) on osteoclast differentiation and function.

Methods

The effect of WESS on osteoclast differentiation was evaluated by counting tartrate resistant acid phosphatase-positive multinucleated cells in bone marrow-derived macrophages system and murine bone marrow cell-osteoblast coculture system. Bone resorption activity of mature osteoclast was examined on a calcium phosphate-coated plate. Actin ring structure of osteoclasts was detected fluorescently by staining for F-actin. Activation of signaling pathways and induction of transcription factors required for osteoclastogenesis were investigated by real-time PCR and Western blotting.

Results

WESS effectively inhibited osteoclast differentiation from its precursors. The inhibitory effect of WESS on osteoclast differentiation was due to the suppression of osteoclastogenic transcription factors, c-Fos and nuclear factor of activated T cells cytoplasmic 1 expression, via preventing receptor activator of nuclear factor-κB ligand-induced early signaling pathways and decreasing c-Fos protein level in osteoclast precursors. Furthermore, WESS suppressed bone resorption activity of osteoclasts by disrupting actin ring structure.

Conclusions

This study demonstrated that WESS inhibits osteoclast differentiation and function. These results suggest that WESS has a potential for treating pathological bone diseases caused by excessive bone resorption.

【 授权许可】

   
2013 Ha et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

【 参考文献 】

• [1]Boyle WJ, Simonet WS, Lacey DL: Osteoclast differentiation and activation. Nature 2003, 423:337-342.
• [2]Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ: Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998, 93:165-176.
• [3]Jurdic P, Saltel F, Chabadel A, Destaing O: Podosome and sealing zone: specificity of the osteoclast model. Eur J Cell Biol 2006, 85:195-202.
• [4]Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, Capparelli C, Morony S, Oliveira-dos-Santos AJ, Van G, Itie A, Khoo W, Wakeham A, Dunstan CR, Lacey DL, Mak TW, Boyle WJ, Penninger JM: OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 1999, 397:315-323.
• [5]Xiong J, Onal M, Jilka RL, Weinstein RS, Manolagas SC, O'Brien CA: Matrix-embedded cells control osteoclast formation. Nat Med 2011, 17:1235-1241.
• [6]Takayanagi H: Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immunol 2007, 7:292-304.
• [7]Yamashita T, Yao Z, Li F, Zhang Q, Badell IR, Schwarz EM, Takeshita S, Wagner EF, Noda M, Matsuo K, Xing L, Boyce BF: NF-kappaB p50 and p52 regulate receptor activator of NF-kappaB ligand (RANKL) and tumor necrosis factor-induced osteoclast precursor differentiation by activating c-Fos and NFATc1. J Biol Chem 2007, 282:18245-18253.
• [8]Grigoriadis AE, Wang ZQ, Cecchini MG, Hofstetter W, Felix R, Fleisch HA, Wagner EF: c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science 1994, 266:443-448.
• [9]Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H, Saiura A, Isobe M, Yokochi T, Inoue J, Wagner EF, Mak TW, Kodama T, Taniguchi T: Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell 2002, 3:889-901.
• [10]Matsuo K, Galson DL, Zhao C, Peng L, Laplace C, Wang KZ, Bachler MA, Amano H, Aburatani H, Ishikawa H, Wagner EF: Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos. J Biol Chem 2004, 279:26475-26480.
• [11]Banu J, Varela E, Fernandes G: Alternative therapies for the prevention and treatment of osteoporosis. Nutr Rev 2012, 70:22-40.
• [12]Wu JN: An illustrated Chinese materia medica. New York: Oxford University Press; 2005.
• [13]Chen DH, Luo X, Yu MY, Zhao YQ, Cheng YF, Yang ZR: Effect of Spatholobus suberectus on the bone marrow cells and related cytokines of mice. Zhongguo Zhong Yao Za Zhi 2004, 29:352-355.
• [14]Lee BJ, Jo IY, Bu Y, Park JW, Maeng S, Kang H, Jang W, Hwang DS, Lee W, Min K, Kim JI, Yoo HH, Lew JH: Antiplatelet effects of Spatholobus suberectus via inhibition of the glycoprotein IIb/IIIa receptor. J Ethnopharmacol 2011, 134:460-467.
• [15]Ravipati AS, Zhang L, Koyyalamudi SR, Jeong SC, Reddy N, Bartlett J, Smith PT, Shanmugam K, Munch G, Wu MJ, Satyanarayanan M, Vysetti B: Antioxidant and anti-inflammatory activities of selected Chinese medicinal plants and their relation with antioxidant content. BMC Complement Altern Med 2012, 12:173. BioMed Central Full Text
• [16]Liao H, Banbury LK, Leach DN: Antioxidant activity of 45 Chinese herbs and the relationship with their TCM characteristics. Evid Based Complement Alternat Med 2008, 5:429-434.
• [17]Soe HG, Oh MS, Kim DH: Immunity responses of the spatholobus suberectus dunn to synovial cells isolated from patients with rheumatoid arthritis. Korean J Oriental Physiol Pathol 2003, 17:780-786.
• [18]Choi JS, Song TW, Kim DH: A study on the effect spatholobus suberectus dunn on the inhibition of arthritis by collagen on the mouse. Kor J Herbology 2003, 18:79-88.
• [19]Lee JH, Kim HN, Yang D, Jung K, Kim HM, Kim HH, Ha H, Lee ZH: Trolox prevents osteoclastogenesis by suppressing RANKL expression and signaling. J Biol Chem 2009, 284:13725-13734.
• [20]Huang H, Chang EJ, Ryu J, Lee ZH, Lee Y, Kim HH: Induction of c-Fos and NFATc1 during RANKL-stimulated osteoclast differentiation is mediated by the p38 signaling pathway. Biochem Biophys Res Commun 2006, 351:99-105.
• [21]Kim HJ, Lee Y, Chang EJ, Kim HM, Hong SP, Lee ZH, Ryu J, Kim HH: Suppression of osteoclastogenesis by N, N-dimethyl-D-erythro-sphingosine: a sphingosine kinase inhibition-independent action. Mol Pharmacol 2007, 72:418-428.
• [22]Lee JH, Jin H, Shim HE, Kim HN, Ha H, Lee ZH: Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal. Mol Pharmacol 2010, 77:17-25.
• [23]Ikeda F, Nishimura R, Matsubara T, Tanaka S, Inoue J, Reddy SV, Hata K, Yamashita K, Hiraga T, Watanabe T, Kukita T, Yoshioka K, Rao A, Yoneda T: Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation. J Clin Invest 2004, 114:475-484.
• [24]Hayden MS, Ghosh S: NF-kappaB, the first quarter-century: remarkable progress and outstanding questions. Genes Dev 2012, 26:203-234.
• [25]Buss H, Dorrie A, Schmitz ML, Hoffmann E, Resch K, Kracht M: Constitutive and interleukin-1-inducible phosphorylation of p65 NF-{kappa}B at serine 536 is mediated by multiple protein kinases including I{kappa}B kinase (IKK)-{alpha}, IKK{beta}, IKK{epsilon}, TRAF family member-associated (TANK)-binding kinase 1 (TBK1), and an unknown kinase and couples p65 to TATA-binding protein-associated factor II31-mediated interleukin-8 transcription. J Biol Chem 2004, 279:55633-55643.
• [26]Yang F, Tang E, Guan K, Wang CY: IKK beta plays an essential role in the phosphorylation of RelA/p65 on serine 536 induced by lipopolysaccharide. J Immunol 2003, 170:5630-5635.
• [27]Zou Z, Zeng F, Xu W, Wang C, Ke Z, Wang QJ, Deng F: PKD2 and PKD3 promote prostate cancer cell invasion by modulating NF-kappaB- and HDAC1-mediated expression and activation of uPA. J Cell Sci 2012, 125:4800-4811.
• [28]Huang H, Ryu J, Ha J, Chang EJ, Kim HJ, Kim HM, Kitamura T, Lee ZH, Kim HH: Osteoclast differentiation requires TAK1 and MKK6 for NFATc1 induction and NF-kappaB transactivation by RANKL. Cell Death Differ 2006, 13:1879-1891.
• [29]Ruocco MG, Maeda S, Park JM, Lawrence T, Hsu LC, Cao Y, Schett G, Wagner EF, Karin M: I{kappa}B kinase (IKK){beta}, but not IKK{alpha}, is a critical mediator of osteoclast survival and is required for inflammation-induced bone loss. J Exp Med 2005, 201:1677-1687.
• [30]Doyle SL, Jefferies CA, O'Neill LA: Bruton's tyrosine kinase is involved in p65-mediated transactivation and phosphorylation of p65 on serine 536 during NFkappaB activation by lipopolysaccharide. J Biol Chem 2005, 280:23496-23501.
• [31]Takayanagi H, Kim S, Matsuo K, Suzuki H, Suzuki T, Sato K, Yokochi T, Oda H, Nakamura K, Ida N, Wagner EF, Taniguchi T: RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta. Nature 2002, 416:744-749.
• [32]Ha H, Kwak HB, Lee SW, Jin HM, Kim HM, Kim HH, Lee ZH: Reactive oxygen species mediate RANK signaling in osteoclasts. Exp Cell Res 2004, 301:119-127.
• [33]Bax BE, Alam AS, Banerji B, Bax CM, Bevis PJ, Stevens CR, Moonga BS, Blake DR, Zaidi M: Stimulation of osteoclastic bone resorption by hydrogen peroxide. Biochem Biophys Res Commun 1992, 183:1153-1158.
• [34]Lee MH, Lin YP, Hsu FL, Zhan GR, Yen KY: Bioactive constituents of Spatholobus suberectus in regulating tyrosinase-related proteins and mRNA in HEMn cells. Phytochemistry 2006, 67:1262-1270.
• [35]Shim SH: 20S proteasome inhibitory activity of flavonoids isolated from Spatholobus suberectus. Phytother Res 2011, 25:615-618.
• [36]Fraga CG: Plant polyphenols: how to translate their in vitro antioxidant actions to in vivo conditions. IUBMB Life 2007, 59:308-315.
• [37]Karieb S, Fox SW: Phytoestrogens directly inhibit TNF-alpha-induced bone resorption in RAW264.7 cells by suppressing c-fos-induced NFATc1 expression. J Cell Biochem 2011, 112:476-487.